Chester County News and Community Website
EXTON, PA — Castle Creek Biosciences announced the recent publication of a preclinical study that found that its experimental in vivo gene therapy treatment resolved biochemical and hepatic histological markers …
Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) states that the independent Data and Safety Monitoring Board (DSMB) for its Phase 1/2 clinical trial of OCU400, the Company’s flagship modifier gene …
Ocugen, Inc. Announces Positive DSMB Recommendation for OCU400-101 Clinical Trial Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the first patient has been recently dosed in the Phase 1/2 clinical trial of OCU400, a modifier gene therapy candidate for …
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 Read More MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the first patient has been recently dosed in the Phase 1/2 clinical trial of OCU400, a modifier gene therapy candidate for …
Ocugen, Inc. Announces First Patient Dosed in Phase 1/2 Clinical Trial for Gene Therapy Candidate OCU400 to Treat Inherited Retinal Degeneration Read More EXTON, PA — Castle Creek Biosciences, Inc. announced it recently acquired Novavita Thera, Inc., a preclinical gene therapy company focused on rare liver and metabolic diseases. The acquisition expands Castle …
Castle Creek Biosciences Acquires Novavita Thera Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) announced that the U.S. Food and Drug Administration (FDA) recently accepted the company’s Investigational New Drug application (IND) to initiate a first-in-human clinical …
Ocugen, Inc. Announces U.S. FDA Acceptance of Investigational New Drug Application Read More
PHILADELPHIA, PA — Scout Bio announced the expansion of their foundational collaboration agreement with the Gene Therapy Program (GTP) at the University of Pennsylvania (Penn) to grant Scout Bio exclusive …
Scout Bio Expands Gene Therapy Collaboration with the University of Pennsylvania Via Next-Generation Vector Technologies Read More